AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « comparison »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
comparing < comparison < comparisons  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 41.
[0-20] [0 - 20][0 - 41][20-40]
Ident.Authors (with country if any)Title
000087 (2011) K. Krüger [Allemagne] ; B. Hellmich [Allemagne] ; A. Rubbert-Roth [Allemagne] ; U. Müller-Ladner [Allemagne] ; A. Kielhorn [Allemagne]Ist der Vergleich verschiedener Studien zur Wirksamkeit von Biologika bei Patienten mit rheumatoider Arthritis möglich?
000088 (2011) Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis]Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach
000094 (2011) Maasa Hama [Japon] ; Takeaki Uehara [Japon] ; Kaoru Takase [Japon] ; Atsushi Ihata [Japon] ; Atsuhisa Ueda [Japon] ; Mitsuhiro Takeno [Japon] ; Kazuya Shizukuishi [Japon] ; Ukihide Tateishi [Japon] ; Yoshiaki Ishigatsubo [Japon]Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab—preliminary data
000105 (2012) M. Gallego-Galisteo ; A. Villa-Rubio ; E. Alegre-Del Rey [Espagne] ; E. Márquez-Fernández ; J. J. Ramos-BáezIndirect comparison of biological treatments in refractory rheumatoid arthritis
000186 (2010) Christoph Strehblow [Autriche] ; Guenther Haberhauer [Autriche] ; Peter Fasching [Autriche]Comparison of different biologic agents in patients with rheumatoid arthritis after failure of the first biologic therapy
000233 (2010) Hiroshi Kato [États-Unis] ; David A. Fox [États-Unis]Are Th17 Cells an Appropriate New Target in the Treatment of Rheumatoid Arthritis?
000296 (2012) Adel Alawadhi [Koweït] ; Khaldoon Alawneh [Jordanie] ; Zeyad Ahmed Alzahrani [Arabie saoudite]The effect of neutralizing antibodies on the sustainable efficacy of biologic therapies: what’s in it for African and Middle Eastern rheumatologists
000461 (2011) Alberto Migliore [Italie, Espagne] ; Emanuele Bizzi [Italie] ; Serena Broccoli [Italie] ; Bruno Laganà [Italie]Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator
000468 (2013) T. Tsuru ; M. Suzaki ; K. Maeda ; H. Nakashima ; T. Eto ; M. Ishibashi ; J. Manabe ; K. Terao [Japon] ; S. IrieAB0580 Selological responce of the H1N1PDM influenza vaccine in patients with rheumatoid arthritis treated with monoclonal antibody therapy or conventional DMARDS, comparison with healthy adult
000495 (2013) I. Yokoe [Japon] ; H. Kobayashi [Japon] ; H. Sato [Japon] ; A. Nishiwaki [Japon]AB0539 Comparison of RA patients in tocilizumab (TCZ) therapy who showed only DAS28(ESR) remission and both DAS28-ESR and SDAI remission
000582 (2013) Y. Kanayama ; T. Kojima ; Y. Hirano ; Y. Yabe [Japon] ; N. Takahashi ; K. Funahashi ; Y. Oishi ; N. IshiguroAB0336 Radiographic progression of cervical lesions in patients with rheumatoid arthritis receiving tocilizumab treatment comparison with infliximab treatment from japanese tbcr
000611 (2013) K. Saito [Japon] ; K. Hanami [Japon] ; S. Hirata [Japon] ; S. Kubo [Japon] ; M. Nawata [Japon] ; K. Yamaoka [Japon] ; S. Nakayamada [Japon] ; K. Nakano [Japon] ; Y. Tanaka [Japon]FRI0251 Comparison of lipid profile including high molecular weight adiponectin (HMW-AN) after treatment with three different biologics in the patients with bio-naïve rheumatoid arthritis (RA)
000674 (2013) Christoph Fiehn [Allemagne] ; Elisabeth Belke-Voss [Allemagne] ; Dietmar Krause [Allemagne] ; Siegfried Wassenberg [Allemagne] ; Rolf Rau [Allemagne]Improved radiological outcome of rheumatoid arthritis: the importance of early treatment with methotrexate in the era of biological drugs
000702 (2013) A. Ogata [Japon]FRI0180 The musashi study: Comparison of subcutaneous tocilizumab monotherapy versus intravenous tocilizumab monotherapy: Results from a double-blind, parallel-group, comparative phase III non-inferiority study in japanese patients with rheumatoid arthritis
000704 (2013) S. Martin-Du-Pan ; D. Neto ; P. Zufferey [Suisse] ; A. Ciurea ; H. Ziswiler [Suisse] ; C. Gabay ; A. FinckhSAT0104 Comparison of Drug Discontinuation to Inefficacy and Adverse Events Between Anti-Tnf Agents and ‘Non-Anti-Tnf Biologic Agents’ in Anti-Tnf Inadequate Responder Rheumatoid Arthritis Patients
000783 (2013) Y. Yonemoto ; K. Okamura ; K. Takeuchi ; M. Matsushita [Japon] ; T. Kaneko ; T. Kobayashi ; T. Aramaki [Japon] ; K. TakagishiTHU0094 Direct comparison of four biological agents in bio-naïve rheumatoid arthritis patients
000787 (2013) Y. Miwa [Japon] ; H. Furuya [Japon] ; R. Yanai [Japon] ; K. Ohtsuka [Japon] ; M. Sato [Japon] ; R. Takahashi [Japon] ; K. Wakabayashi [Japon] ; N. Yajima [Japon] ; T. Kasama [Japon] ; M. Hosaka [Japon]AB0447 Comparison of efficacy of four biological agents for rheumatoid arthritis patients using the HRQOL questionnaire and depression scale
000850 (2013) A. Östör [Royaume-Uni] ; J. A. Román Ivorra [Espagne] ; J. Wollenhaupt [Allemagne] ; C. Mpofu [Suisse] ; C. Bernasconi [Suisse] ; J. Sibilia [France] ; V. Bykerk [États-Unis, Canada]FRI0179 Comparison of tocilizumab as monotherapy or in combination with non-biological disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) and an inadequate response to anti-TNF agents
000867 (2013) A. Diamantopoulos [Royaume-Uni] ; C. Lereun [Irlande (pays)] ; R. Westhovens [Belgique] ; F. Dejonckheere [Suisse]THU0308 Indirect comparison of ACR response of biologic treatments in active SJIA
000893 (2013) Y. Okuda [Japon] ; M. Ohnishi [Japon] ; K. Takasugi [Japon]THU0091 Comparison of the clinical utility of anti-IL-6 receptor antibody therapy and anti-TNF therapy in aa amyloidosis in rheumatic disease
000925 (2012) P. A. Laires [Portugal] ; F. Exposto [Portugal] ; R. Mesquita [Portugal] ; A. P. Martins [Portugal] ; L. Cunha-Miranda [Portugal] ; J. E. Fonseca [Portugal]Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "comparison" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "comparison" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    comparison
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021